95 related articles for article (PubMed ID: 23123502)
1. Rho-kinase negatively regulates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kondo A; Tokuda H; Kato K; Matsushima-Nishiwaki R; Kuroyanagi G; Mizutani J; Kozawa O; Otsuka T
Biochimie; 2013 Apr; 95(4):719-24. PubMed ID: 23123502
[TBL] [Abstract][Full Text] [Related]
2. Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts.
Natsume H; Tokuda H; Adachi S; Takai S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Niida S; Mizutani J; Kozawa O; Otsuka T
Bone; 2010 Apr; 46(4):1068-74. PubMed ID: 20114091
[TBL] [Abstract][Full Text] [Related]
3. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Hanai Y; Adachi S; Minamitani C; Mizutani J; Otsuka T; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):41-6. PubMed ID: 18771907
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Rho-kinase in prostaglandin E(1)-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblast-like MC3T3-E1 cells.
Adachi S; Tokuda H; Matsushima-Nishiwaki R; Kato K; Natsume H; Minamitani C; Mizutani J; Otsuka T; Kozawa O
Prostaglandins Other Lipid Mediat; 2009 Nov; 90(1-2):1-6. PubMed ID: 19524699
[TBL] [Abstract][Full Text] [Related]
5. Rho-kinase limits BMP-4-stimulated osteocalcin synthesis in osteoblasts: regulation of the p38 MAP kinase pathway.
Kondo A; Tokuda H; Matsushima-Nishiwaki R; Kuroyanagi G; Yamamoto N; Mizutani J; Kozawa O; Otsuka T
Life Sci; 2014 Feb; 96(1-2):18-25. PubMed ID: 24368139
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Rho-kinase in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts.
Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O
Int J Mol Med; 2009 Jul; 24(1):77-82. PubMed ID: 19513538
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Rho-kinase in prostaglandin F2alpha-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O
Mol Cell Endocrinol; 2008 Sep; 291(1-2):27-32. PubMed ID: 18586382
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase regulates thrombin-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
Kato K; Otsuka T; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
Int J Mol Med; 2011 Oct; 28(4):653-8. PubMed ID: 21750859
[TBL] [Abstract][Full Text] [Related]
9. Rho-kinase inhibitors decrease TGF-beta-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Kuno M; Takai S; Matsushima-Nishiwaki R; Minamitani C; Mizutani J; Otsuka T; Harada A; Adachi S; Kozawa O; Tokuda H
Biochem Pharmacol; 2009 Jan; 77(2):196-203. PubMed ID: 18996357
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated protein kinase regulates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kondo A; Otsuka T; Kato K; Matsushima-Nishiwaki R; Kuroyanagi G; Mizutani J; Tokuda H; Kozawa O
Int J Mol Med; 2013 Jun; 31(6):1457-62. PubMed ID: 23588610
[TBL] [Abstract][Full Text] [Related]
11. Rho-kinase regulates endothelin-1-stimulated IL-6 synthesis via p38 MAP kinase in osteoblasts.
Tokuda H; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Doi T; Harada A; Takai S; Kozawa O
Biochem Biophys Res Commun; 2007 Nov; 362(4):799-804. PubMed ID: 17825250
[TBL] [Abstract][Full Text] [Related]
12. Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression.
Kanazawa I; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E139-46. PubMed ID: 19001547
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
[TBL] [Abstract][Full Text] [Related]
14. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
Varga F; Spitzer S; Klaushofer K
Calcif Tissue Int; 2004 Apr; 74(4):382-7. PubMed ID: 15255076
[TBL] [Abstract][Full Text] [Related]
15. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells.
Yamaguchi S; Tanabe K; Takai S; Matsushima-Nishiwaki R; Adachi S; Iida H; Kozawa O; Dohi S
Neurochem Int; 2009 Nov; 55(6):438-45. PubMed ID: 19427347
[TBL] [Abstract][Full Text] [Related]
17. Intraradial administration of fasudil inhibits augmented Rho kinase activity to effectively dilate the spastic radial artery during coronary artery bypass grafting surgery.
Takagi T; Okamoto Y; Tomita S; Sato A; Yamaguchi S; Takuwa Y; Watanabe G
J Thorac Cardiovasc Surg; 2011 Aug; 142(2):e59-65. PubMed ID: 21397262
[TBL] [Abstract][Full Text] [Related]
18. Activation of p38 mitogen-activated protein kinase mediates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Ishisaki A; Tokuda H; Yoshida M; Hirade K; Kunieda K; Hatakeyama D; Shibata T; Kozawa O
Mol Cell Endocrinol; 2004 Feb; 214(1-2):189-95. PubMed ID: 15062557
[TBL] [Abstract][Full Text] [Related]
19. The thyroid hormone receptor (TR) beta-selective agonist GC-1 inhibits proliferation but induces differentiation and TR beta mRNA expression in mouse and rat osteoblast-like cells.
Beber EH; Capelo LP; Fonseca TL; Costa CC; Lotfi CF; Scanlan TS; Gouveia CH
Calcif Tissue Int; 2009 Apr; 84(4):324-33. PubMed ID: 19280098
[TBL] [Abstract][Full Text] [Related]
20. Triiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-jun, and induction of osteocalcin expression.
Varga F; Rumpler M; Luegmayr E; Fratzl-Zelman N; Glantschnig H; Klaushofer K
Calcif Tissue Int; 1997 Nov; 61(5):404-11. PubMed ID: 9351883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
